CD8A and myeloid sarcoma: Another study comparing patients with MS and healthy donors confirmed that clonally expanded CD8+ and CD4+ T cells in CSF expressed genes that are involved in T cell activation and cytotoxicity and were different from the T cell phenotype found in the blood (13).